![](/img/cover-not-exists.png)
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
Kantarjian, Hagop M., Martinelli, Giovanni, Jabbour, Elias J., Quintás-Cardama, Alfonso, Ando, Kiyoshi, Bay, Jacques-Olivier, Wei, Andrew, Gröpper, Stefanie, Papayannidis, Cristina, Owen, Kate, Pike,Volume:
119
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.28113
Date:
July, 2013
File:
PDF, 286 KB
english, 2013